Literature DB >> 22740887

Early clinical diagnosis of synchronous multiple primary lung cancer.

Xinying Xue1, Qingliang Xue, Na Wang, Lina Zhang, Lina Guo, Xinfu Li, Junping Sun, Jianxin Wang.   

Abstract

The diagnosis of synchronous multiple primary lung cancer (SMPLC) remains a formidable challenge. The aim of the present study was to identify useful clues for the clinical diagnosis of SMPLC, in particular for the early stages. The medical records of 10 patients diagnosed with SMPLC with different histological types were analyzed retrospectively. Chest computed tomography (CT) findings showed two pulmonary lesions in all patients. The two lesions displayed malignant characteristics of primary lung cancer. The levels of a number of tumor markers, including carcinoembryonic antigen, neuron-specific enolase, cytokeratin fragment 21-1, squamous cell carcinoma and CA125 increased in 2 patients. Auxiliary examinations of other physical sites in these patients did not show signs of neoplasm metastasis. Two tumors were separately staged and appropriate treatment was carried out based on the revised stage, which provided more benefits for SMPLC patients. The diagnosis of SMPLC might be delayed or mistaken owing to its similarity to neoplasm metastasis. A high index of awareness is required for the early diagnosis of this disease. The malignant characteristics of primary lung cancer in various lesions may be valuable clues for the diagnosis of SMPLC. Alterations in the levels of tumor markers may be a poor diagnostic tool for the detection of SMPLC. Separate biopsies for different pulmonary masses should be performed for clinical staging as soon as possible and reasonable treatment based on the stage should also be selected.

Entities:  

Year:  2011        PMID: 22740887      PMCID: PMC3362344          DOI: 10.3892/ol.2011.452

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

2.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

Authors:  M T van Rens; A B de la Rivière; H R Elbers; J M van Den Bosch
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

3.  [Surgical treatment for bilateral multiple lung cancers].

Authors:  S Matsuge; Y Hosokawa; K Satoh; Y Murakami; T Yamakawa; H Hatakeyama; M Ishigooka; S Yamazaki
Journal:  Kyobu Geka       Date:  2000-02

4.  Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels.

Authors:  K Goto; T Kodama; F Hojo; K Kubota; R Kakinuma; T Matsumoto; H Ohmatsu; I Sekine; K Nagai; Y Nishiwaki
Journal:  Cancer       Date:  1998-03-15       Impact factor: 6.860

5.  Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.

Authors:  S Niho; Y Nishiwaki; K Goto; H Ohmatsu; T Matsumoto; F Hojo; Y Ohe; R Kakinuma; T Kodama
Journal:  Lung Cancer       Date:  2000-03       Impact factor: 5.705

6.  [Therapeutic strategy for secondary lung cancer].

Authors:  Hiroyuki Miura; Norio Nakajima; Hidenobu Takahashi; Masao Kinoshita; Norihiko Ikeda
Journal:  Kyobu Geka       Date:  2010-10

7.  Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).

Authors:  T Shibayama; H Ueoka; K Nishii; K Kiura; M Tabata; K Miyatake; T Kitajima; M Harada
Journal:  Lung Cancer       Date:  2001-04       Impact factor: 5.705

Review 8.  ProGRP: a new biomarker for small cell lung cancer.

Authors:  Rafael Molina; Xavier Filella; Josep M Augé
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

9.  Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Authors:  Rafael Molina; Josep M Augé; Xavier Bosch; José M Escudero; Nuria Viñolas; Ramón Marrades; José Ramírez; Enric Carcereny; Xavier Filella
Journal:  Tumour Biol       Date:  2009-06-09

10.  Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.

Authors:  L G Jørgensen; K Osterlind; J Genollá; S A Gomm; J R Hernández; P W Johnson; J Løber; T A Splinter; M Szturmowicz
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more
  6 in total

1.  Double primary non-small cell lung cancer with synchronous small cell lung cancer N2 nodes: a case report.

Authors:  Apostolos S Gogakos; Dimitrios Paliouras; Thomas Rallis; Fotios Chatzinikolaou; Persefoni Xirou; Katerina Tsirgogianni; Drosos Tsavlis; Nikos Sachpekidis; Kosmas Tsakiridis; Andreas Mpakas; Konstantinos Zarogoulidis; Athanasios Zissimopoulos; Paul Zarogoulidis; Nikolaos Barbetakis
Journal:  Ann Transl Med       Date:  2015-07

2.  Surgical treatment for synchronous multiple primary lung cancer: Is it possible to achieve both curability and preservation of the pulmonary function?

Authors:  Takuya Watanabe; Masayuki Tanahashi; Eriko Suzuki; Naoko Yoshii; Hiroyuki Tsuchida; Shogo Yobita; Kensuke Iguchi; Suiha Uchiyama; Minori Nakamura
Journal:  Thorac Cancer       Date:  2021-09-30       Impact factor: 3.500

3.  Development and Validation of a Nomogram for Predicting Overall Survival in Patients with Second Primary Small Cell Lung Cancer After Non-Small Cell Lung Cancer: A SEER-Based Study.

Authors:  Ju Zhu; Haoming Shi; Haoyu Ran; Qiancheng Lai; Yue Shao; Qingchen Wu
Journal:  Int J Gen Med       Date:  2022-04-02

4.  Triple synchronous primary lung cancer: a case report and review of the literature.

Authors:  Muhammad Kashif; Puvanalingam Ayyadurai; Luong Thanha; Misbahuddin Khaja
Journal:  J Med Case Rep       Date:  2017-09-01

Review 5.  [Diagnosis and Treatment for Multiple Primary Lung Cancer].

Authors:  Lijie Tan; Jun Yin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-03-20

6.  Adenocarcinoma of Lung and Bronchial Carcinoid Presenting as Double Synchronous Primary Lung Cancer: A Case Report and Review of Literature.

Authors:  Lakshmi Saladi; Sai Mounica Maddu; Masooma Niazi; Ajsza Matela
Journal:  World J Oncol       Date:  2018-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.